$NHC
NATIONAL HEALTHCARE CORP Stock $nhc

$nhc Overview Financials Valuation SEC Filings Company Website

2018 Q1 Form 10-Q Financial Statement

#000143774918008685 Filed on May 04, 2018

Income Statement

Concept	2018 Q1	2017 Q1
Revenue	$243.0M	$238.5M
YoY Change	1.85%	3.9%
Cost Of Revenue	$140.1M	$138.1M
YoY Change	1.45%	6.23%
Gross Profit	$102.9M	$100.5M
YoY Change	2.39%	0.9%
Gross Profit Margin	42.35%	42.13%
Selling, General & Admin	$10.20M	$10.10M
YoY Change	0.99%	-1.94%
% of Gross Profit	9.91%	10.05%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$10.34M	$10.30M
YoY Change	0.46%	10.06%
% of Gross Profit	10.05%	10.24%
Operating Expenses	$85.80M	$83.50M
YoY Change	2.75%	3.09%
Operating Profit	$15.88M	$15.86M
YoY Change	0.12%	-9.99%
Interest Expense	$1.240M	$1.058M
YoY Change	17.2%	10.9%
% of Operating Profit	7.81%	6.67%
Other Income/Expense, Net	-$3.065M	$4.768M
YoY Change	-164.28%	-0.1%
Pretax Income	-$2.699M	$20.63M
YoY Change	-113.08%	-7.88%
Income Tax	$200.0K	$7.999M
% Of Pretax Income		38.77%
Net Earnings	-$2.791M	$12.73M
YoY Change	-121.93%	-7.09%
Net Earnings / Revenue	-1.15%	5.34%
Basic Earnings Per Share	-$0.18	$0.84
Diluted Earnings Per Share	-$0.18	$0.84
COMMON SHARES
Basic Shares Outstanding	15.22M	15.17M
Diluted Shares Outstanding	15.22M	15.21M

Balance Sheet

Concept	2018 Q1	2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$73.03M	$183.4M
YoY Change	-60.18%	4.74%
Cash & Equivalents	$54.96M	$47.10M
Short-Term Investments	$18.07M	$136.3M
Other Short-Term Assets	$31.40M	$29.50M
YoY Change	6.44%	-3.28%
Inventory	$7.266M	$7.320M
Prepaid Expenses
Receivables	$85.01M	$83.34M
Other Receivables	$3.000M	$900.0K
Total Short-Term Assets	$305.2M	$304.5M
YoY Change	0.23%	2.76%
LONG-TERM ASSETS
Property, Plant & Equipment	$546.1M	$557.4M
YoY Change	-2.03%	3.2%
Goodwill	$17.60M	$17.60M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments	$27.50M	$36.40M
YoY Change	-24.45%	-2.15%
Other Assets	$208.0M	$217.1M
YoY Change	-4.21%	-6.27%
Total Long-Term Assets	$754.1M	$774.5M
YoY Change	-2.64%	0.36%
TOTAL ASSETS
Total Short-Term Assets	$305.2M	$304.5M
Total Long-Term Assets	$754.1M	$774.5M
Total Assets	$1.059B	$1.079B
YoY Change	-1.83%	1.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$16.70M	$18.60M
YoY Change	-10.22%	3.91%
Accrued Expenses	$72.40M	$67.50M
YoY Change	7.26%	-13.57%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due		$3.500M
YoY Change		6.06%
Total Short-Term Liabilities	$131.7M	$132.1M
YoY Change	-0.31%	-4.86%
LONG-TERM LIABILITIES
Long-Term Debt	$100.0M	$120.0M
YoY Change	-16.67%	0.0%
Other Long-Term Liabilities	$16.13M	$16.83M
YoY Change	-4.15%	0.25%
Total Long-Term Liabilities	$116.1M	$136.8M
YoY Change	-15.13%	0.03%
TOTAL LIABILITIES
Total Short-Term Liabilities	$131.7M	$132.1M
Total Long-Term Liabilities	$116.1M	$136.8M
Total Liabilities	$367.6M	$402.3M
YoY Change	-8.62%	45.96%
SHAREHOLDERS EQUITY
Retained Earnings	$477.5M	$397.8M
YoY Change	20.03%	5.92%
Common Stock	$152.0K	$152.0K
YoY Change	0.0%	-0.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$691.1M	$675.9M
YoY Change
Total Liabilities & Shareholders Equity	$1.059B	$1.079B
YoY Change	-1.83%	1.02%

Cashflow Statement

Concept	2018 Q1	2017 Q1
OPERATING ACTIVITIES
Net Income	-$2.791M	$12.73M
YoY Change	-121.93%	-7.09%
Depreciation, Depletion And Amortization	$10.34M	$10.30M
YoY Change	0.46%	10.06%
Cash From Operating Activities	$13.31M	$13.01M
YoY Change	2.27%	-26.62%
INVESTING ACTIVITIES
Capital Expenditures	$7.100M	$8.066M
YoY Change	-11.98%	-39.95%
Acquisitions
YoY Change
Other Investing Activities	$1.300M	$34.30M
YoY Change	-96.21%	1805.56%
Cash From Investing Activities	-$5.828M	$26.27M
YoY Change	-122.18%	-411.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	-$200.0K	-$817.0K
YoY Change	-75.52%	-108.76%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-8.159M	-7.063M
YoY Change	15.52%	-519.67%
NET CHANGE
Cash From Operating Activities	13.31M	13.01M
Cash From Investing Activities	-5.828M	26.27M
Cash From Financing Activities	-8.159M	-7.063M
Net Change In Cash	-681.0K	32.22M
YoY Change	-102.11%	193.58%
FREE CASH FLOW
Cash From Operating Activities	$13.31M	$13.01M
Capital Expenditures	$7.100M	$8.066M
Free Cash Flow	$6.206M	$4.945M
YoY Change	25.5%	15.03%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2017Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3696000
CY2018Q1	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	22094000
CY2018Q1	nhc	Annual Excess Coverage AnnualExcessCoverage	9000000
CY2017Q1	nhc	Annual Excess Coverage AnnualExcessCoverage	9000000
CY2018Q1	nhc	Direct Business Coverage Statutory Limits DirectBusinessCoverageStatutoryLimits	1000000
CY2018Q1	nhc	Dividends And Other Net Realized Gains And Losses On Sales Of Securities DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities	1803000
CY2017Q1	nhc	Dividends And Other Net Realized Gains And Losses On Sales Of Securities DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities	1724000
CY2018Q1	nhc	Entrance Fee Deposits Refunds EntranceFeeDepositsRefunds	-159000
CY2017Q1	nhc	Entrance Fee Deposits Refunds EntranceFeeDepositsRefunds	-519000
CY2018Q1	nhc	Equity Securities Fv Ni Gross Unrealized Gain EquitySecuritiesFvNiGrossUnrealizedGain	93421000
CY2017Q4	nhc	Equity Securities Fv Ni Gross Unrealized Gain EquitySecuritiesFvNiGrossUnrealizedGain	108934000
CY2018Q1	nhc	Equity Securities Fv Ni Gross Unrealized Loss EquitySecuritiesFvNiGrossUnrealizedLoss	29000
CY2017Q4	nhc	Equity Securities Fv Ni Gross Unrealized Loss EquitySecuritiesFvNiGrossUnrealizedLoss	24000
CY2017Q1	nhc	Income Tax Rate Reconciliation Exercise Of Stock Options Amount IncomeTaxRateReconciliationExerciseOfStockOptionsAmount	124000
CY2018Q1	nhc	Increase Decrease In Due To Third Party Payors IncreaseDecreaseInDueToThirdPartyPayors	-234000
CY2017Q1	nhc	Increase Decrease In Due To Third Party Payors IncreaseDecreaseInDueToThirdPartyPayors	668000
CY2018Q1	nhc	Management And Accounting Services Fees Revenue ManagementAndAccountingServicesFeesRevenue	3708000
CY2017Q1	nhc	Management And Accounting Services Fees Revenue ManagementAndAccountingServicesFeesRevenue	3859000
CY2018Q1	nhc	Miscellaneous Revenue MiscellaneousRevenue	337000
CY2017Q1	nhc	Miscellaneous Revenue MiscellaneousRevenue	381000
CY2017Q1	nhc	Noncontrolling Interest Increase From Capital Contribution NoncontrollingInterestIncreaseFromCapitalContribution	970000
CY2018Q1	nhc	Number Of Assisted Living Facilities NumberOfAssistedLivingFacilities	24
CY2018Q1	nhc	Number Of Beds NumberOfBeds	9623
CY2018Q1	nhc	Number Of Homecare Programs NumberOfHomecarePrograms	36
CY2018Q1	nhc	Number Of Independent Living Facilities NumberOfIndependentLivingFacilities	5
CY2018Q1	nhc	Number Of Skilled Nursing Centers NumberOfSkilledNursingCenters	76
CY2018Q1	nhc	Other Revenues OtherRevenues	11269000
CY2017Q1	nhc	Other Revenues OtherRevenues	11284000
CY2018Q1	nhc	Primary Insurance Coverage Amount Per Incident PrimaryInsuranceCoverageAmountPerIncident	1000000
CY2018Q1	nhc	Primary Insurance Coverage Amount Per Location PrimaryInsuranceCoverageAmountPerLocation	3000000
CY2018Q1	nhc	Revenue From Contract With Customer Including Assessed Tax Percentage RevenueFromContractWithCustomerIncludingAssessedTaxPercentage	1
CY2017Q1	nhc	Revenue From Contract With Customer Including Assessed Tax Percentage RevenueFromContractWithCustomerIncludingAssessedTaxPercentage	1
CY2018Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	17155000
CY2017Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	17389000
CY2018Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	16715000
CY2017Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	15978000
CY2018Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	85006000
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	86767000
CY2018Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	44483000
CY2017Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	67102000
CY2018Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	419697000
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	409429000
CY2018Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2916000
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	67504000
CY2018Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	216287000
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	215659000
CY2017Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	92000
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	428000
CY2018Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	428000
CY2017Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	92000
CY2018Q1	us-gaap	Assets Assets	1059221000
CY2017Q4	us-gaap	Assets Assets	1096526000
CY2018Q1	us-gaap	Assets Current AssetsCurrent	305160000
CY2017Q4	us-gaap	Assets Current AssetsCurrent	329311000
CY2018Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	179000
CY2017Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	885000
CY2018Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	3870000
CY2017Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	3149000
CY2018Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	166448000
CY2017Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	167277000
CY2018Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	286324000
CY2017Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	305480000
CY2018Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	196623000
CY2017Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	197453000
CY2018Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	71931000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	77657000
CY2018Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	69398000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	76943000
CY2018Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	77295000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	70331000
CY2018Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	76171000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	70157000
CY2018Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	797000
CY2018Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	796000
CY2018Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	17222000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	18492000
CY2018Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	17187000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	18499000
CY2018Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	162756000
CY2017Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	166395000
CY2018Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	18067000
CY2017Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	21012000
CY2018Q1	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	144689000
CY2017Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	145383000
CY2018Q1	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3751000
CY2017Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.388
CY2017Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	23052000
CY2018Q1	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	30767000
CY2018Q1	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	5200000
CY2018Q1	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	5200000
CY2018Q1	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	5200000
CY2018Q1	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	5200000
CY2018Q1	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	5200000
CY2018Q1	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	4767000
CY2018Q1	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	4922000
CY2018Q1	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	25845000
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	54962000
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	59118000
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	47096000
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	67421000
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31589000
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	66740000
CY2017Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	63809000
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-681000
CY2017Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	32220000
CY2018Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.48
CY2017Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.45
CY2018Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000
CY2018Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15219533
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15212133
CY2018Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15219533
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15212133
CY2018Q1	us-gaap	Common Stock Value CommonStockValue	152000
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	152000
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5010000
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	12161000
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-108000
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-95000
CY2018Q1	us-gaap	Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount	2887000
CY2017Q4	us-gaap	Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount	2887000
CY2018Q1	us-gaap	Costs And Expenses CostsAndExpenses	227078000
CY2017Q1	us-gaap	Costs And Expenses CostsAndExpenses	222674000
CY2018Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
CY2018Q1	us-gaap	Customer Refundable Fees CustomerRefundableFees	8668000
CY2017Q4	us-gaap	Customer Refundable Fees CustomerRefundableFees	8827000
CY2018Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	11000
CY2017Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	34000
CY2018Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-5206000
CY2017Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1657000
CY2018Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	5256000
CY2017Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3226000
CY2018Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	12580000
CY2017Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	18376000
CY2018Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	4884000
CY2017Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	4867000
CY2018Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10342000
CY2017Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10295000
CY2018Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10342000
CY2017Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10295000
CY2017Q1	us-gaap	Dividends Common Stock DividendsCommonStock	6831000
CY2018Q1	us-gaap	Dividends Common Stock DividendsCommonStock	7305000
CY2018Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	7305000
CY2017Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	7297000
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.84
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.84
CY2018Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0742
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-2699000
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	20632000
CY2018Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-6586000
CY2017Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1526000
CY2018Q1	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.3168
CY2018Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	6917000
CY2018Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P4Y
CY2018Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	2254000
CY2017Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	2609000
CY2018Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-15517000
CY2017Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss
CY2018Q1	us-gaap	Goodwill Goodwill	17600000
CY2017Q4	us-gaap	Goodwill Goodwill	17600000
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7999000
CY2017	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	-8488000
CY2018Q1	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	855000
CY2017Q1	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	49000
CY2017Q1	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	175000
CY2018Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	1527000
CY2017Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	5465000
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	737000
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-14000
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1761000
CY2017Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	808000
CY2018Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-22619000
CY2017Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-23936000
CY2018Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2030000
CY2017Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2232000
CY2018Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits
CY2017Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-662000
CY2018Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-3938000
CY2017Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-4665000
CY2018Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	113000
CY2017Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-188000
CY2018Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-1882000
CY2017Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	4695000
CY2018Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	337000
CY2017Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	528000
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	631000
CY2017Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1280000
CY2018Q1	us-gaap	Increase Decrease In Self Insurance Reserve IncreaseDecreaseInSelfInsuranceReserve	2971000
CY2017Q1	us-gaap	Increase Decrease In Self Insurance Reserve IncreaseDecreaseInSelfInsuranceReserve	3661000
CY2018Q1	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	1692000
CY2017Q1	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	1559000
CY2018Q1	us-gaap	Interest Expense InterestExpense	1240000
CY2017Q1	us-gaap	Interest Expense InterestExpense	1058000
CY2018Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1718000
CY2017Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1518000
CY2018Q1	us-gaap	Inventory Net InventoryNet	7266000
CY2017Q4	us-gaap	Inventory Net InventoryNet	7153000
CY2018Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	27499000
CY2017Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	36339000
CY2018Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	140095000
CY2017Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	138055000
CY2018Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	10229000
CY2017Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	10088000
CY2018Q1	us-gaap	Liabilities Liabilities	367584000
CY2017Q4	us-gaap	Liabilities Liabilities	393094000
CY2018Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1059221000
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1096526000
CY2018Q1	us-gaap	Liabilities Current LiabilitiesCurrent	131652000
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	155065000
CY2018Q1	us-gaap	Long Term Debt LongTermDebt	100000000
CY2017Q4	us-gaap	Long Term Debt LongTermDebt	100000000
CY2018Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent
CY2017Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent
CY2018Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	100000000
CY2017Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	100000000
CY2018Q1	us-gaap	Malpractice Loss Contingency Number Of Claims MalpracticeLossContingencyNumberOfClaims	63
CY2018Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	123568000
CY2017Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	139085000
CY2018Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	16132000
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15795000
CY2018Q1	us-gaap	Minority Interest MinorityInterest	586000
CY2017Q4	us-gaap	Minority Interest MinorityInterest	694000
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-8159000
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-7063000
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5828000
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	26272000
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	13306000
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	13011000
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-2791000
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	12728000
CY2017Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-95000
CY2018Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-108000
CY2018Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	1422000
CY2017Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	1450000
CY2018Q1	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	11398000
CY2017Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	11801000
CY2018Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
CY2018Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2018Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	10
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	15883000
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	15864000
CY2018Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	305000000
CY2018Q1	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	34200000
CY2018Q1	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	34200000
CY2018Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	34200000
CY2018Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	34200000
CY2018Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	34200000
CY2018Q1	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	134000000
CY2018Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	5532000
CY2017Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	5485000
CY2018Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	207984000
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	217896000
CY2017Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-567000
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2219000
CY2018Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	11000
CY2017Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	34000
CY2018Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-590000
CY2017Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-408000
CY2018Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-2798000
CY2017Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-941000
CY2018Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	65172000
CY2017Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	63178000
CY2018Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	14312000
CY2017Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	16194000
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3065000
CY2017Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4768000
CY2017	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
CY2018Q1	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
CY2018Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	867000
CY2017Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock
CY2018Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	7297000
CY2017Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	6818000
CY2018Q1	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates
CY2017Q1	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	176000
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7100000
CY2017Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8066000
CY2018Q1	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	2694000
CY2017Q1	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	2291000
CY2018Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3478000
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2864000
CY2018Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;">Prior Period Classifications</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">Certain amounts in prior periods have been reclassified to conform with current period presentation.</div></div></div></div></div>
CY2018Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	431000
CY2017Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	2918000
CY2018Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1067000
CY2017Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	817000
CY2018Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders
CY2017Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	970000
CY2017Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0
CY2018Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0
CY2018Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	3535000
CY2017Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	33887000
CY2018Q1	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	3535000
CY2017Q1	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	33887000
CY2018Q1	us-gaap	Profit Loss ProfitLoss	-2899000
CY2017Q1	us-gaap	Profit Loss ProfitLoss	12633000
CY2018Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	965774000
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	958748000
CY2018Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	546077000
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	549319000
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1276355
CY2018Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	11000
CY2017Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	34000
CY2018Q1	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	903000
CY2017Q1	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	851000
CY2018Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	11778000
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	72.94
CY2018Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	959000
CY2017Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1178000
CY2017Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	16713000
CY2018Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9864000
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	6397000
CY2018Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1914000
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1906000
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	477528000
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	419423000
CY2018Q1	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">D</div><div style="display: inline; font-style: italic;">eferred Revenue </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"> </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">Deferred revenue includes the deferred gain on the sale of assets to National Health Corporation (“National”), the non-refundable portion (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div>) of CCRC entrance fees being amortized over the remaining life expectancies of the residents, and premiums received within our workers’ compensation and professional liability companies that are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> yet earned.</div></div></div></div></div>
CY2018Q1	us-gaap	Revenues Revenues	242961000
CY2017Q1	us-gaap	Revenues Revenues	238538000
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	55.48
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	71.19
CY2018Q1	us-gaap	Self Insurance Reserve SelfInsuranceReserve	96246000
CY2017Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	93275000
CY2018Q1	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	27931000
CY2017Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	27409000
CY2018Q1	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	68315000
CY2017Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	65866000
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	428000
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	92000
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0317
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.031
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.1584
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.166
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0237
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0208
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	15000
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1125443
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	58854
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	251000
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	177959
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1239407
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	71.10
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	251000
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	37500
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	52.93
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	51.25
CY2018Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	48.74
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	72.96
CY2018Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	60.95
CY2018Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	1276355
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y146D
CY2017Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y292D
CY2018Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	71.10
CY2018Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P3Y255D
CY2017	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	48995
CY2018Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	21906
CY2017Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	817000
CY2018Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1067000
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	691051000
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	702738000
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	669611000
CY2017Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	676725000
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	703432000
CY2018Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	691637000
CY2018Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	867000
CY2018Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;">Estimates and Assumptions</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and could cause our reported net income to vary significantly from period to period.</div></div></div></div></div>
CY2018Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15216635
CY2017Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15212133
CY2018Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15216635
CY2017Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15173491

Files In Submission

Name	View Source	Status
0001437749-18-008685-index-headers.html	Edgar Link	pending
0001437749-18-008685-index.html	Edgar Link	pending
0001437749-18-008685.txt	Edgar Link	pending
0001437749-18-008685-xbrl.zip	Edgar Link	pending
ex_111269.htm	Edgar Link	pending
ex_111270.htm	Edgar Link	pending
ex_111271.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nhc-20180331.xml	Edgar Link	completed
nhc-20180331.xsd	Edgar Link	pending
nhc-20180331_cal.xml	Edgar Link	unprocessable
nhc-20180331_def.xml	Edgar Link	unprocessable
nhc-20180331_lab.xml	Edgar Link	unprocessable
nhc-20180331_pre.xml	Edgar Link	unprocessable
nhc20180331_10q.htm	Edgar Link	pending
nhc20180331_10qimg001.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHC
NATIONAL HEALTHCARE CORP Stock $nhc

2018 Q1 Form 10-Q Financial Statement

#000143774918008685 Filed on May 04, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHC NATIONAL HEALTHCARE CORP Stock $nhc

2018 Q1 Form 10-Q Financial Statement

#000143774918008685 Filed on May 04, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHC
NATIONAL HEALTHCARE CORP Stock $nhc